MRI Interventions, Inc. Obtains $17.5M Strategic Investment From PTC Therapeutics, Inc. And Petrichor Healthcare Capital Management

MRI Interventions, Inc. (NASDAQ:MRIC) (the "Company"), a leading platform neurosurgery company, today announced preliminary and unaudited results for the quarter ended December 31, 2019. Additionally, the

Benzinga · 01/13/2020 13:12

MRI Interventions, Inc. (NASDAQ:MRIC) (the "Company"), a leading platform neurosurgery company, today announced preliminary and unaudited results for the quarter ended December 31, 2019. Additionally, the Company announced a $17.5 million strategic investment from PTC Therapeutics, Inc. ("PTC") and Petrichor Healthcare Capital Management ("Petrichor").